Endo- and extranasal sequelae of Treacher-Collins syndrome

• Conditions: Treacher-Collins syndrome; 10028396; 10010613

• Registration Number: NL-OMON37845
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 22

Inclusion Criteria

diagnosis Treacher Collins syndrome
informed consent
ability to speak Dutch
18 years or above

Exclusion Criteria

no ability to speak Dutch
age < 18 years

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Study parameters/endpoints<br /><br>Main study parameter/endpoint<br /><br>Main study parameters/endpoints will be a detailed description of all endo- and<br /><br>extranasal deformities (description of affected anatomical structures), nasal<br /><br>functioning and satisfaction with nasal appearance (as addressed in NAFEQ<br /><br>score).All are described in more detail in the -following- study procedures </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoint is a change in the current treatment of TCS as will be<br /><br>described in (as part of ) a treatment protocol.</p><br>